Inyx Inc banner
I

Inyx Inc
OTC:IYXI

Watchlist Manager
Inyx Inc
OTC:IYXI
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: $53.1

Inyx Inc
Investor Relations

Inyx, Inc. is pharmaceutical company, which develops and acquires niche pharmaceutical products and drug delivery systems for key therapeutic areas, including respiratory and dermatological applications. The company is headquartered in New York City, New York and currently employs 572 full-time employees. The company went IPO on 2003-02-19. Its operations are focused on the development of both prescriptions, over the counter pharmaceutical products, and specialty consulting services. Also, the Company utilizes niche drug delivery capabilities to develop its own products. The product and service categories of the Company include Metered Dose Inhalers (MDIs) (CFC & HFA), Dry Powder Inhalers (DPIs), Metered Dose Pump Sprays (nasal and oral), Hydrocarbon Foam Aerosols, Saline Aerosols, Sterile Solutions/Injectables, Solid Dose, Formulation Services, Analytical Development Validation, Stability Services, Regulatory Support and Integrated Project Management.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Steven Handley
President & Director
No Bio Available
Mr. Jay M. Green
Executive VP, Director of Corporate Development & Director
No Bio Available
Ms. Carole Richardson
Corporate Administration Manager of Inyx Pharma Ltd.
No Bio Available
Mr. William Kelly
Vice President of Corporate Communications & Investor Relations
No Bio Available
Mr. Stephen Beckman
Vice President of Sales & Marketing and Commercial Development
No Bio Available

Contacts

Address
NEW YORK
New York City
825 Third Avenue, 40Th Floor,
Contacts
+12128381111
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett